Recent insider trends for Evolent Health, Inc. (NYSE:EVH) have caught the attention of investors. Patters in insider activity can help analysts formulate an outlook for a stock. In the case of EVH, the data has a lot to say about how the stock might perform going forward.
Institutions own 98.69% of Evolent Health, Inc. (EVH)’s shares. The total value of these holdings, in millions, is $1,028. Among active positions in the latest quarter, 110 holders increased their positions by a total of 21.23 million shares, 65 holders decreased the positions by a total of 9.11 million shares, and 25 holders held their positions. This works out to a net increase in ownership of 12.11 million shares, and suggests that institutions are feeling bullish about the stock.
Among new and sold out positions, 34 holders initiated new positions by a total of 4.07 million shares and 34 holders exited their positions by a total of 5.92 million shares. This nets out to a decrease of 1.85 million shares and is another bearish sign for EVH.
Insider ownership increased by a total of 0 shares, which suggests that EVH’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a different story: insiders executed 21 buys and 59 sells, and ownership decreased by a net of 7.77 million shares.
The analysis of insider buying and selling trends can be extended to the aggregate level. Short interest, which represents the number of a stock’s shares currently being shorted, captures what the market as a whole feels about a stock. Evolent Health, Inc. (NYSE:EVH)’s short interest is 16.24 million shares, or % of the float. This represents an increase of 1% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks.
Insider data can help an investor form an outlook on a stock, but it’s important to supplement this data with other information such as technical indicators to form a more complete view. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that EVH is a buy, which implies that EVH is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Evolent Health, Inc. (NYSE:EVH) is undervalued.